| Submit Press Release
| Submit Website
(CityRegions.Com, June 06, 2018 ) The North America biobanks market is expected to register a CAGR of around 6% during the forecast period of 2018–2023. Biobanks are the biorepository where various biomaterials are stored for research purposes. A few decades ago, biobanks were primarily restricted to established economies carrying out breakthrough research in biological sciences. The biobank industry has come a long way since then, with an increasing number of biobanking services and global presence.
Key Developments in the Market:
• January 2018: Bio-Techne acquired Atlanta Biologicals Inc.
Major Players: ATLANTA BIOLOGICALS, INC., (BIO-TECHNE), BIOLIFE SOLUTIONS, INC., BIONICHE PHARMA USA LLC, CELL & TISSUE SYSTEMS LLC, ESSENTIAL PHARMACEUTICALS, GENZYME CORPORATION, LIFELINE SCIENTIFIC INC., and SIGMA ALDRICH CORPORATION, among others.
Ask for Sample Report@ http://orbisresearch.com/contacts/request-sample/2131229
Advancements in Stem Cell and Regenerative Medicine Research
Research in regenerative medicine is becoming more intense and advanced in the developed countries, especially in the United States. These advancements in regenerative medicine show considerable potential for disease reversal. Stem cells can treat many hitherto untreatable diseases and are likely to be the therapeutic option for many diseases in the future. Its therapeutic application in the treatment of amyotrophic lateral sclerosis (ALS), Alzheimer's disease, other autoimmune diseases, diabetes, musculoskeletal diseases, ocular diseases, rare genetic diseases, and cancer are being researched through clinical trials. Several of these studies have generated promising results. According to clinicaltrials.gov, currently, there are around 196 studies registered for research on regenerative medicine. The increasing popularity of regenerative medicine research is attracting substantial funding from both public and private investors. This rise in regenerative medicine research has also driven the demand for biobanks, which act as the reservoir for stem cells and other biological samples that are used in regenerative medicine research. The other factors, such as rising incidences of chronic diseases, advances in drug discovery, and R&D funding and investments by government and non-governmental organizations are driving the North American biobanks market.
Biobanks are under ethical oversight from independent reviewers, while the governance process is intended to be public. Oversight may come at the local level, or from an institutional review board, which includes research, particularly medical research. Specific institutional review boards enforce standards set by their respective country’s government. As of now, many countries use laws modeled upon various biobank governance recommendations, which have been proposed internationally. However, there are no internationally accepted set of governance guidelines, which can be designed to work with biobanks. Many existing biobanks typically adapt to the recommendations of guidelines that are accepted for human-subject research and include newer ones, as they are added to the existing guidelines.
The idea of establishing a powerful national population blood-based resource for researchers was first proposed in 1999. Since then, many detailed protocols, ethics, and other government regulations have been developed, while subjecting biobanks to the very highest degree of scrutiny, consultation, and review. However, lack of parity in international set of guidelines has led to regulatory issues in many countries.Some countries have strict regulatory guidelines, which would eventually hinder the growth of the North America biobank market. Therefore, this lack of a defined set of regulations and guidelines, and the irregular regulatory frameworks among the underdeveloped and developing countries are restraining the expansion of the North America biobank market. The other factor, such as cost constraints is also hindering the market.
Browse complete report with table of content and list of figures@ http://orbisresearch.com/reports/index/north-america-biobanks-market-segmented-by-equipment-media-service-application-and-geography-growth-trends-and-forecast-2018-2023
United States Leads the Market in North America
The United States biobanks market held the largest market share in 2017 in North America due to increasing research in biological sciences, and with huge investments by different pharmaceutical and biotech companies, the utilization of biobanks are increasing consistently.
Reasons to Purchase the Report
• Follow the current and future North America biobanks market outlook in the developed and emerging markets
• Analyzing various perspectives of the market with the help of Porter’s Five Forces Analysis.
• Identify the segment that is expected to dominate the market.
• Identify the regions that are expected to witness the fastest growth during the forecast period.
• Identify the latest developments, market shares, and strategies employed by the major market players.
• 3-month analyst support along with the Market Estimate sheet (in Excel).
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.
Table of Content
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
7. Market Segmentation
8. Competitive Landscape
9. Key Players
10. Future of the Market
For discount click here@ http://orbisresearch.com/contacts/discount/2131229
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas - 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
For More PR’s: http://orbisnewsrelease.com
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research
Follow us on Twitter: https://twitter.com/orbisresearch
+1 (214) 884-6817